GRAND WUYAO (JIANGSU) PHARMACEUTICAL CO., LTD

Grand Wuyao (Jiangsu) Pharmaceutical Co., Ltd. (formerly Lianyungang Jari Pharmaceutical Co., Ltd) has been committed to R&D, production and sales of chemical active pharmaceutical ingredients (APIs), intermediates and formulations since its establishment in 2004. As an important anti-tumor raw material drug base of Grand Pharma, Grand Wuyao (Jiangsu) has become a leading player in the domestic pharmaceutical industry with advanced research and development capacities, excellent production processes, and strict quality management. Grand Wuyao (Jiangsu) has two modern production sites covering an area of 150,000m, equipped with complete office buildings, R&D centers, production workshops and warehouse faculties. It has passed various domestic and interactional certification including the new national GMP certification, on-site inspections by the USFDA, and the PIC/S international certification. Additionally, we have received numerous honorary titles such as "National High-tech Enterprise," "Jiangsu Postdoctoral Innovation Practice Base,” Jiangsu Provincial Enterprise Technology Center” and “Jiangsu Provincial Specialized, Refined, Unique and Innovative Small and Medium-sized Enterprise" and etc., which fully demonstrate the company's technical strength and market competitiveness.